Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies.

Therapeutic drug monitoring - 1 Apr 2004

Eap C B, Jaquenoud Sirot E, Baumann P

Abstract excerpt

As for other drugs, there is a large interindividual variability of the plasma concentrations of antidepressants for a given dose. Within the last 2 decades, a very large number of pharmacogenetic studies have made it possible to understand the importance of genetic factors on the disposition of drugs in the organism, many of them at the levels of drug metabolism. Polymorphism of CYP2D6 and of other...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Clinical Trials as Topic
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Monitoring

Share to Genotype

Share to Patient Compliance

Share to Pharmacogenetics

Source

Identifiers

PMID: 15228156
DOI: 10.1097/00007691-200404000-00011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies.PMID 15228156Read ↗

Pharmacogenetics-guided dose modifications of antidepressants.Semantic proximity Read ↗

Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics.Semantic proximity Read ↗

Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.Semantic proximity Read ↗

Cytochrome P450 2D6 genotyping: potential role in improving treatment outcomes in psychiatric disorders.Semantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.Semantic proximity Read ↗

Pharmacogenetics: From Bench to ByteSemantic proximity Read ↗

Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.Semantic proximity Read ↗

[The value of pharmacogenetic tests in antidepressive medication therapy].Semantic proximity Read ↗

Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.Semantic proximity Read ↗

The impact of the CYP2D6-polymorphism on dose recommendations for current antidepressants.Semantic proximity Read ↗

Pharmacogenomics and antidepressant drugs.Semantic proximity Read ↗

The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.